Clinical trial
Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis
NCT00048347 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00048347 |
|---|---|
| Title | Interferon-beta1a (AVONEX) Treatment of Ulcerative Colitis |
| Official title | An Open-Label, Pilot Study of Type I Interferon (AVONEX) Treatment of Ulcerative Colitis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | AVONEX |
| Enrollment | 18 |
| Start date | Oct 1, 2002 |
| Primary completion | Jun 1, 2008 |
| Completion | May 1, 2010 |
| First posted | Oct 30, 2002 |
| Last update posted | Sep 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: